3rd Diabetes Partnering and Deal Making Conference on April 29 - 30, 2013 in Boston, MA
- Start Date:
- Monday, 29 April, 2013
- End Date:
- Tuesday, 30 April, 2013 4:00am
With more than 400 drug candidates for diabetes in active development and in light of the recent US Food and Drug Administration (FDA) guidance to assess cardiovascular risk in clinical trials, the burden to develop novel drugs is greater and the barrier for success has become higher than ever. What will be the next block-buster drug target for T1DM and T2DM? How does the recent FDA guidance affect our approach to develop new medications for diabetes? How do different size companies adapt the best strategy to be competitive in this field? GTC's 3rd Diabetes Partnering and Deal Making Conference, part of the 3rd Diabetes Summit, is a partnering and business development conference that gives companies an opportunity to network with high-level executives and explore potential collaborations, learn about relevant issues and deals that will affect the industry.
This important meeting will be held on April 29-30, 2013 in Boston, MA. The conference will bring together the leading experts on diabetes from both industry and academia to discuss business strategies and opportunities under the current regulatory landscape. We look forward to seeing you at the conference! Conference Date: April 29-30, 2013
1 Ave De Lafayette Boston,
Conference organized by GTC
GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders academic institutions government organizations and the financial community. GTC (Global Technology Community) LLC is a privately held company founded in 2002.
- 635 W. Foothill Blvd. Monrovia CA, 91016